CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
Gentamicin infusions twice a week for six monthsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00451074
NCT00451074Phase 1Completed
CompareCT.gov

A Six Month Randomized, Clinical Trial of Gentamicin in Duchenne Muscular Dystrophy Subjects With Stop Codon Mutations

Nationwide Children's Hospital·interventional·Posted Mar 23, 2007·Updated Mar 23, 2012

In Brief

A Phase 1 clinical trial evaluating Gentamicin infusions twice a week for six months for Duchenne Muscular Dystrophy. Completed, enrolled 12 participants across 3 sites.

Detailed Summary

The purpose of this study is to determine the safety of giving intravenous (IV) gentamicin to boys with Duchenne muscular dystrophy who have stop codon mutations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDuchenne Muscular Dystrophy
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS)

Timeline

Phase 1CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 23, 2007
Enrollment StartMar 1, 2007
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 19.3 years ago

Interventions

Gentamicin infusions twice a week for six monthsdrug

Gentamicin infusions twice a week